rata de sentina said:
As I've said before, they should still have these gel images on file. The current method of analysing these images is less prone to false negatives than the old method. They don't need the sample just the image from the ccd camera of the gel. It's been shown that using different parameters and computerised analysis you can improve the detection rate, the sensitivity and the window following dosing.
The issue is that it is a subjective assay and the 80% criteria is just a crude attempt to quantitate it. At the end of the day CAS might not have been comfortable with that subjectivity but people who look at these things all the time will know "doped to the gills" when they see it on the gel. Subsequently of course the analysis has been refined because scientists were sick of looking at gels of people who were clearly doping but getting off.
Actually, I think they knew "doped to the gills" under the old system, too, but the linked article in the OP makes it clear what the problem is (the same problem with all doping tests): in order to minimize false positives, a standard is used that is certain to allow many false negatives. The new method might be better, it might show that a suspicious result back then is a clear positive today, but I'm sure it still includes many false negatives. Any test is going to have a substantial overlap between a typical doping profile and the far upper end of normal physiology. We all know that EPO use in the peloton is common, yet there are still very few busts.
Anyway, I can't beleive they are still stuffing about with this stupid IEF test. They should just subject the whole back catalog from the freezer to mass spec and go to town on them. They need to get some proper protein chemists on the job and stop fluffing about.
Ayotte is apparently working on this:
J Mass Spectrom. 2008 Jul;43(7):924-35.
Low LC-MS/MS detection of glycopeptides released from pmol levels of recombinant erythropoietin using nanoflow HPLC-chip electrospray ionization.
Groleau PE, Desharnais P, Coté L, Ayotte C.
I wonder, though, if it might not be necessary to use mass spec. According to this reference:
Blood. 2001 Dec 15;98(13):3626-34.
Sugar profiling proves that human serum erythropoietin differs from recombinant human erythropoietin.
Skibeli V, Nissen-Lie G, Torjesen P.
the biggest difference between rhEPO and natural EPO is that the synthetic protein has more sialic acid groups. Perhaps you could just first purify EPO from urine (which also would be necessary in an approach involving mass spec), remove sialic acid enzymatically, then measure the ratio of it to total EPO protein. Seems to me that this would be a lot faster and easier than mass spec, and avoid some of the complications of the latter.
However, either of these approaches is going to suffer from the same major problem that bedevils the current gel method. If the ratio of natural to synthetic EPO is high in a urine sample, it’s difficult to detect the key differences between the two molecules. Interestingly, I discovered that back in 2003 someone applied for a patent for a monoclonal antibody that was claimed to be specific for rhEPO. That would be the gold standard if possible, though of course you would need a different Ab for each new form of synthetic EPO. I don’t know what became of this procedure, though.